本页面由Tiger Trade Technology Pte. Ltd.提供服务

Acumen Pharmaceuticals, Inc.

1.86
-0.1650-8.17%
成交量:31.93万
成交额:61.07万
市值:1.34亿
市盈率:-1.13
高:2.00
开:2.00
低:1.84
收:2.02
52周最高:3.60
52周最低:1.50
股本:7,221.28万
流通股本:3,704.59万
量比:1.81
换手率:0.86%
股息:- -
股息率:- -
每股收益(TTM):-1.6370
每股收益(LYR):-2.0035
净资产收益率:-120.50%
总资产收益率:-45.77%
市净率:2.34
市盈率(LYR):-0.93

数据加载中...

2022/05/16

季度报告

10-Q - Quarterly report [Sections 13 or 15(d)]
2022/03/29

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2022/03/28

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2022/03/28

重要事件披露

8-K - Current report
2022/02/16

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/15

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/02/14

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/27

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2022/01/03

重要事件披露

8-K - Current report
2021/12/02

持股变动声明

4 - Statement of changes in beneficial ownership of securities
2021/07/16

超过5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/07/13

超过5%披露

SC 13G - Statement of acquisition of beneficial ownership by individuals
2021/07/07

重要事件披露

8-K - Current report
2021/07/02

员工持股计划

S-8 - Securities to be offered to employees in employee benefit plans
2021/06/28

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/28

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/24

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/24

[修订]招股说明书

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/16

SEC问询函

CORRESP [Cover] - Correspondence
2021/06/09

SEC问询函

CORRESP [Cover] - Correspondence